BloodThinnerHelp.com reports on another Xarelto lawsuit which alleges the drug caused uncontrollable bleeding and ultimately death. This particular case, number 2:14-cv-00159-cr, was filed in Vermont. The complaint, filed by the daughter of the deceased, alleged that Xarelto caused her father’s unstoppable parenchymal hemorrhage and subsequent death. This fatal brain hemorrhage came less than a month after the victim had begun taking Xarelto to treat his atrial fibrillation.
Atrial fibrillation is a condition which causes the heart to beat irregularly and generally faster than normal. The condition can make it more difficult for the heart to effectively circulate blood throughout the body, and can cause blood clots or strokes. For this reason, many individuals with atrial fibrillation use blood thinners preventatively.
In many of the current Xarelto lawsuits, plaintiffs mention that it is an especially dangerous blood thinner. Xarelto is a new type of blood thinner, and is often considered more dangerous due to the fact that it has no known antidote. When individuals taking Xarelto suffer hemorrhages or injuries that cause internal or external bleeds, the blood is unable to clot due to the medicine, and physicians can do nothing to reverse the drug’s effects. They have to resort to life-saving measures such as blood transfusions to try to keep patients alive in these instances.
Traditional blood thinners are different. If a patient is injured and bleeding while taking a traditional blood thinner such as warfarin, they are able to be treated with vitamin K which counteracts the effects of the drug and allows their blood to clot. Xarelto does not respond to vitamin K, so, although it was initially thought of as a revolutionary new type of blood thinner, it is now commonly thought of as significantly more dangerous than traditional anticoagulants.
Xarelto lawsuits are filed against manufacturers Bayer AG and Janssen Pharmaceuticals, a division of Johnson & Johnson. Many of the complaints allege that the manufacturers neglected to properly warn consumers of the dangers associated with the drug, instead focusing their marketing efforts on showcasing the convenience the new blood thinner could provide. Unlike traditional blood thinners, Xarelto does not require regular monitoring by a physician, dosage adjustments, or special diets. The drug is a one-size-fits-all pill, which was originally regarded as a plus, but has since come under much scrutiny.
Xarelto lawsuits continue to appear across the U.S., and have now been consolidated to form multidistrict litigation, under MDL 2592. Currently, Attorney Marc Goldich is working to ensure that anyone who has suffered adverse health effects after using Xarelto is able to fully explore their legal rights. These individuals may be entitled to compensation. At this time, Attorney Goldich is offering completely free and confidential consultations to those involved.
For additional information on Xarelto, the pending litigation, or to ask questions, please contact Marc Goldich, Esq. by calling 866-425-8902.
###
Contact BloodThinnerHelp.com:
Marc Goldich
866-425-8902
1500 Walnut Street, 4th Floor, Philadelphia, PA 19102.
